About Frontida BioPharm
Frontida BioPharm is a company based in Exton (United States) founded in 2016 was acquired by Adare Pharma Solutions in December 2021.. Frontida BioPharm has raised $8.35 million across 1 funding round from investors including Adare Pharma Solutions. The company has 243 employees as of December 31, 2022. Frontida BioPharm operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Exton, United States
- Employees 243 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Frontida Biopharm, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.35 M (USD)
in 1 rounds
-
Latest Funding Round
$8.35 M (USD), Series A
Aug 09, 2016
- Investors
-
Employee Count
243
as on Dec 31, 2022
-
Acquired by
Adare Pharma Solutions
(Dec 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Frontida BioPharm
Frontida BioPharm has successfully raised a total of $8.35M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.35 million completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $8.3M
-
First Round
First Round
(09 Aug 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2016 | Amount | Series A - Frontida BioPharm | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Frontida BioPharm
Frontida BioPharm has secured backing from 1 investor. Prominent investors backing the company include Adare Pharma Solutions. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CDMO manufacturing solid drugs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Frontida BioPharm
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Frontida BioPharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Frontida Biopharm Comparisons
Competitors of Frontida BioPharm
Frontida BioPharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| domain | founded_year | HQ Location |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| domain | founded_year | HQ Location |
APIs and finished products are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Frontida Biopharm
Frequently Asked Questions about Frontida BioPharm
When was Frontida BioPharm founded?
Frontida BioPharm was founded in 2016.
Where is Frontida BioPharm located?
Frontida BioPharm is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
Is Frontida BioPharm a funded company?
Frontida BioPharm is a funded company, having raised a total of $8.35M across 1 funding round to date. The company's 1st funding round was a Series A of $8.35M, raised on Aug 09, 2016.
How many employees does Frontida BioPharm have?
As of Dec 31, 2022, the latest employee count at Frontida BioPharm is 243.
What does Frontida BioPharm do?
Frontida Biopharm, an affiliate of Frontage Laboratories that is focussed on providing CDMO services for the manufacturing of immediate and controlled release oral solid dose products. It provides the capability to manufacture highly potent active ingredients (HPAIs), combination products and DEA schedules II V products. It has a patented Duragran granulation process which claims to enhance the drug loading and creates better engineered and cost efficient controlled release products. Along with Frontage Laboratories, the company offers Clinical Trial Materials manufacturing, serialised packaging, warehousing, and stability services.
Who are the top competitors of Frontida BioPharm?
Frontida BioPharm's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Who are Frontida BioPharm's investors?
Frontida BioPharm has 1 investor. Key investors include Adare Pharma Solutions.